On consolidated basis
Quarter ended September 2024
compared with Quarter ended June 2024.
Net sales (including other operating income) of LTIMindtree has increased 3.18%
to Rs 9432.9 crore.
Operating profit margin has jumped
from 17.57% to 18.01%, leading to 5.80% rise in operating profit to Rs 1,699.30
crore. Employee cost decreased from 64.39% to 63.76%.
Other expenses rose from 18.04% to 18.23%.
Other income rose 31.62% to Rs 298.9
crore. PBIDT rose 9% to Rs 1998.2 crore. Provision for
interest fell 2.90% to Rs 70.3 crore. Loan funds rose to Rs 2,325.60
crore as of 30 September 2024 from Rs 2,302.50 crore as of 30 June
2024. Inventories rose to Rs 3.20 crore as of 30 September 2024 from
Rs 3.10 crore as of 30 June 2024. Sundry debtors were higher at Rs
6,091.10 crore as of 30 September 2024 compared to Rs 5,498.00 crore as of 30
June 2024. Cash and bank balance declined from Rs 2,350.10 crore as
of 30 June 2024 to Rs 2,344.40 crore as of 30 September
2024. Investments rose to Rs 9,664.30 crore as of 30 September 2024
from Rs 9,018.60 crore as of 30 June 2024 .
PBDT rose 9.49% to Rs 1927.9
crore. Provision for depreciation rose 2.51% to Rs 241.1
crore. Fixed assets increased to Rs 4,735.00 crore as of 30
September 2024 from Rs 4,353.20 crore as of 30 June 2024. Intangible
assets declined from Rs 1,486.30 crore to Rs 1,212.80 crore.
Profit before tax grew 10.57% to Rs
1,686.80 crore. Share of profit/loss were nil in both the
periods. Provision for tax was expense of Rs 435.2 crore, compared
to Rs 390.5 crore. Effective tax rate was 25.80% compared to 25.60%.
Minority interest decreased 53.85%
to Rs 0.60 crore. Net profit attributable to owners of the company
increased 10.34% to Rs 1,251.00 crore.
Equity capital stood at Rs 29.60
crore as of 30 September 2024 to Rs 29.60 crore as of 30 June
2024. Per share face Value remained same at Rs 1.00.
Promoters’ stake was 68.60% as of 30
September 2024 ,compared to 68.60% as of 30 June 2024 .
Quarter ended September 2024 compared with Quarter ended September 2023.
Net sales (including other operating income) of LTIMindtree has increased 5.92%
to Rs 9432.9 crore. Sales of Banking Financial Services segment has
gone up 3.25% to Rs 3,357.30 crore (accounting for 35.59% of total
sales). Sales of Manufacturing segment has gone up 7.12% to Rs
1,708.30 crore (accounting for 18.11% of total sales). Sales of High
Tech Media & Entertainment segment has gone up 13.30% to Rs 2,395.50 crore
(accounting for 25.40% of total sales). Sales of CPG Retail Pharma
segment has gone up 0.23% to Rs 1,370.00 crore (accounting for 14.52% of total
sales). Sales of Health & Public Services segment has gone up
4.17% to Rs 601.80 crore (accounting for 6.38% of total sales).
Profit before interest, tax and
other unallocable items (PBIT) has jumped 4.17% to Rs 1,699.30
crore. PBIT of Banking Financial Services segment fell 1.59% to Rs
550.30 crore (accounting for 32.38% of total PBIT). PBIT of
Manufacturing segment rose 5.18% to Rs 255.70 crore (accounting for 15.05% of
total PBIT). PBIT of High Tech Media & Entertainment segment
rose 4.85% to Rs 527.50 crore (accounting for 31.04% of total
PBIT). PBIT of CPG Retail Pharma segment fell 3.48% to Rs 258.10
crore (accounting for 15.19% of total PBIT). PBIT of Health &
Public Services segment rose 84.10% to Rs 107.70 crore (accounting for 6.34% of
total PBIT).
PBIT margin of Banking Financial
Services segment fell from 17.20% to 16.39%. PBIT margin of
Manufacturing segment fell from 15.24% to 14.97%. PBIT margin of
High Tech Media & Entertainment segment fell from 23.80% to
22.02%. PBIT margin of CPG Retail Pharma segment fell from 19.56% to
18.84%. PBIT margin of Health & Public Services segment rose
from 10.13% to 17.90%. Overall PBIT margin fell from 18.32% to
18.01%.
Operating profit margin has declined
from 18.32% to 18.01%, leading to 4.17% rise in operating profit to Rs 1,699.30
crore. Employee cost decreased from 63.79% to 63.76%.
Other expenses rose from 17.89% to 18.23%. Expenses
from contract fell from 7.54% to 7.18%.
Other income rose 108.73% to Rs
298.9 crore. PBIDT rose 12.61% to Rs 1998.2
crore. Provision for interest rose 49.57% to Rs 70.3
crore. Loan funds rose to Rs 2,325.60 crore as of 30 September 2024
from Rs 1,742.10 crore as of 30 September 2023. Inventories declined
from Rs 3.50 crore as of 30 September 2023 to Rs 3.20 crore as of 30 September
2024. Sundry debtors were lower at Rs 6,091.10 crore as of 30
September 2024 compared to Rs 6,634.60 crore as of 30 September 2023. Cash
and bank balance rose to Rs 2,344.40 crore as of 30 September 2024 from Rs
2,216.80 crore as of 30 September 2023. Investments rose to Rs
9,664.30 crore as of 30 September 2024 from Rs 6,765.90 crore as of 30
September 2023 .
PBDT rose 11.60% to Rs 1927.9
crore. Provision for depreciation rose 15.80% to Rs 241.1
crore. Fixed assets increased to Rs 4,735.00 crore as of 30
September 2024 from Rs 3,286.20 crore as of 30 September
2023. Intangible assets declined from Rs 1,533.50 crore to Rs 1,212.80
crore.
Profit before tax grew 11.02% to Rs
1,686.80 crore. Share of profit/loss were nil in both the
periods. Provision for tax was expense of Rs 435.2 crore, compared
to Rs 357 crore. Effective tax rate was 25.80% compared to 23.50%.
Minority interest increased 20% to
Rs 0.60 crore. Net profit attributable to owners of the company
increased 7.68% to Rs 1,251.00 crore.
Equity capital stood at Rs 29.60
crore as of 30 September 2024 to Rs 29.60 crore as of 30 September
2023. Per share face Value remained same at Rs 1.00.
Promoters’ stake was 68.60% as of 30
September 2024 ,compared to 68.66% as of 30 September 2023 .
year-to-date (YTD) results analysis.
Net sales (including other operating income) of LTIMindtree has increased 5.50%
to Rs 18575.5 crore. Sales of Banking Financial Services segment has
gone up 0.99% to Rs 6,576.80 crore (accounting for 35.41% of total
sales). Sales of Manufacturing segment has gone up 9.57% to Rs
3,397.20 crore (accounting for 18.29% of total sales). Sales of High
Tech Media & Entertainment segment has gone up 13.44% to Rs 4,736.50 crore
(accounting for 25.50% of total sales). Sales of CPG Retail Pharma
segment has gone up 0.49% to Rs 2,698.10 crore (accounting for 14.53% of total
sales). Sales of Health & Public Services segment has gone up
2.86% to Rs 1,166.90 crore (accounting for 6.28% of total sales).
Profit before interest, tax and
other unallocable items (PBIT) has jumped 1.18% to Rs 3,305.40
crore. PBIT of Banking Financial Services segment fell 6.13% to Rs
1,058.80 crore (accounting for 32.03% of total PBIT). PBIT of
Manufacturing segment rose 2.24% to Rs 520.00 crore (accounting for 15.73% of
total PBIT). PBIT of High Tech Media & Entertainment segment
rose 4.72% to Rs 1,030.30 crore (accounting for 31.17% of total
PBIT). PBIT of CPG Retail Pharma segment fell 4.20% to Rs 493.10
crore (accounting for 14.92% of total PBIT). PBIT of Health &
Public Services segment rose 54.29% to Rs 203.20 crore (accounting for 6.15% of
total PBIT).
PBIT margin of Banking Financial
Services segment fell from 17.32% to 16.10%. PBIT margin of
Manufacturing segment fell from 16.40% to 15.31%. PBIT margin of
High Tech Media & Entertainment segment fell from 23.56% to
21.75%. PBIT margin of CPG Retail Pharma segment fell from 19.17% to
18.28%. PBIT margin of Health & Public Services segment rose
from 11.61% to 17.41%. Overall PBIT margin fell from 18.55% to
17.79%.
Operating profit margin has declined
from 18.55% to 17.79%, leading to 1.18% rise in operating profit to Rs 3,305.40
crore. Employee cost increased from 64.06% to 64.07%.
Other expenses rose from 17.39% to 18.14%. Expenses
from contract fell from 7.46% to 7.18%.
Other income rose 91.41% to Rs 526
crore. PBIDT rose 8.18% to Rs 3831.4 crore. Provision for
interest rose 53.44% to Rs 142.7 crore. Loan funds rose to Rs
2,325.60 crore as of 30 September 2024 from Rs 1,742.10 crore as of 30
September 2023. Inventories declined from Rs 3.50 crore as of 30
September 2023 to Rs 3.20 crore as of 30 September 2024. Sundry
debtors were lower at Rs 6,091.10 crore as of 30 September 2024 compared to Rs
6,634.60 crore as of 30 September 2023. Cash and bank balance rose
to Rs 2,344.40 crore as of 30 September 2024 from Rs 2,216.80 crore as of 30
September 2023. Investments rose to Rs 9,664.30 crore as of 30
September 2024 from Rs 6,765.90 crore as of 30 September 2023 .
PBDT rose 6.96% to Rs 3688.7
crore. Provision for depreciation rose 21.23% to Rs 476.3
crore. Fixed assets increased to Rs 4,735.00 crore as of 30 September
2024 from Rs 3,286.20 crore as of 30 September 2023. Intangible
assets declined from Rs 1,533.50 crore to Rs 1,212.80 crore.
Profit before tax grew 5.13% to Rs
3,212.40 crore. Share of profit/loss were nil in both the
periods. Provision for tax was expense of Rs 825.7 crore, compared
to Rs 741.1 crore. Effective tax rate was 25.70% compared to 24.25%.
Minority interest increased 46.15%
to Rs 1.90 crore. Net profit attributable to owners of the company
increased 3.09% to Rs 2,384.80 crore.
Equity capital stood at Rs 29.60
crore as of 30 September 2024 to Rs 29.60 crore as of 30 September
2023. Per share face Value remained same at Rs 1.00.
Promoters’ stake was 68.60% as of 30
September 2024 ,compared to 68.66% as of 30 September 2023 .
Cash flow from operating activities
increased to Rs 2,175.90 crore for YTD ended September 2024 from Rs 2,104.90
crore for YTD ended September 2023. Cash flow used in acquiring
fixed assets during the YTD ended September 2024 stood at Rs 491.20 crore,
compared to Rs 399.30 crore during the YTD ended September 2023.
Full year results analysis.
Net sales (including other operating income) of LTIMindtree has increased 7.03%
to Rs 35517 crore. Sales of Banking Financial Services segment has
gone up 4.83% to Rs 12,840.60 crore (accounting for 36.15% of total
sales). Sales of Manufacturing segment has gone up 17.40% to Rs
6,587.50 crore (accounting for 18.55% of total sales). Sales of High
Tech Media & Entertainment segment has gone up 4.12% to Rs 8,398.70 crore
(accounting for 23.65% of total sales). Sales of CPG Retail Pharma
segment has gone up 4.77% to Rs 5,356.00 crore (accounting for 15.08% of total
sales). Sales of Health & Public Services segment has gone up
8.86% to Rs 2,334.20 crore (accounting for 6.57% of total sales).
Profit before interest, tax and
other unallocable items (PBIT) has jumped 4.58% to Rs 6,387.40
crore. PBIT of Banking Financial Services segment fell 0.61% to Rs
2,162.10 crore (accounting for 33.85% of total PBIT). PBIT of
Manufacturing segment rose 14.06% to Rs 1,015.40 crore (accounting for 15.90%
of total PBIT). PBIT of High Tech Media & Entertainment segment
rose 8.56% to Rs 1,870.30 crore (accounting for 29.28% of total
PBIT). PBIT of CPG Retail Pharma segment fell 0.04% to Rs 1,003.10
crore (accounting for 15.70% of total PBIT). PBIT of Health &
Public Services segment rose 6.55% to Rs 336.50 crore (accounting for 5.27% of
total PBIT).
PBIT margin of Banking Financial
Services segment fell from 17.76% to 16.84%. PBIT margin of
Manufacturing segment fell from 15.87% to 15.41%. PBIT margin of
High Tech Media & Entertainment segment rose from 21.36% to
22.27%. PBIT margin of CPG Retail Pharma segment fell from 19.63% to
18.73%. PBIT margin of Health & Public Services segment fell
from 14.73% to 14.42%. Overall PBIT margin fell from 18.41% to
17.98%.
Operating profit margin has declined
from 18.41% to 17.98%, leading to 4.58% rise in operating profit to Rs 6,387.40
crore. Employee cost increased from 62.92% to 64.00%.
Other expenses fell from 18.67% to 18.01%. Expenses
from contract fell from 8.52% to 7.21%.
Other income rose 26.04% to Rs 701.9
crore. PBIDT rose 6.37% to Rs 7089.3 crore. Provision for
interest rose 47.41% to Rs 221.7 crore. Loan funds rose to Rs
2,070.60 crore as of 31 March 2024 from Rs 1,541.20 crore as of 31 March
2023. Inventories declined from Rs 3.30 crore as of 31 March 2023 to
Rs 3.00 crore as of 31 March 2024. Sundry debtors were higher at Rs
5,706.00 crore as of 31 March 2024 compared to Rs 5,623.40 crore as of 31 March
2023. Cash and bank balance declined from Rs 2,932.00 crore as of 31
March 2023 to Rs 2,816.00 crore as of 31 March 2024. Investments
rose to Rs 8,743.60 crore as of 31 March 2024 from Rs 5,458.30 crore as of 31
March 2023 .
PBDT rose 5.43% to Rs 6867.6
crore. Provision for depreciation rose 13.31% to Rs 818.9
crore. Fixed assets increased to Rs 4,338.80 crore as of 31 March
2024 from Rs 3,392.20 crore as of 31 March 2023. Intangible assets
increased from Rs 1,189.20 crore to Rs 1,192.70 crore.
Profit before tax grew 4.44% to Rs
6,048.70 crore. Share of profit/loss were nil in both the
periods. Provision for tax was expense of Rs 1464.1 crore, compared
to Rs 1381.2 crore. Effective tax rate was 24.21% compared to
23.85%.
Minority interest increased 25% to
Rs 2.50 crore. Net profit attributable to owners of the company
increased 3.94% to Rs 4,582.10 crore.
Equity capital stood at Rs 29.60
crore as of 31 March 2024 to Rs 29.60 crore as of 31 March 2023. Per
share face Value remained same at Rs 1.00.
Promoters’ stake was 68.60% as of 31
March 2024 ,compared to 68.68% as of 31 March 2023 .
Cash flow from operating activities
increased to Rs 5,669.50 crore for year ended March 2024 from Rs 3,094.60 crore
for year ended March 2023. Cash flow used in acquiring fixed assets
during the year ended March 2024 stood at Rs 843.20 crore, compared to Rs
939.30 crore during the year ended March 2023.
Dividend: The Board has declared interim dividend
of Rs 20 per equity share of Rs 1 each.
Management
Comment:
Commenting on the performance of the
company Mr. Debashis Chatterjee, Chief Executive Officer and Managing Director,
LTIMindtree, said: “Q2 was a good quarter marked by broad-based sequential
growth experienced across all our verticals and geos, helping us register a
dollar growth of 2.8%. We had several multi-year deal closures, including a USD
200 million+ deal. Continued deal momentum in key verticals and significant Q2
hiring, including freshers, positions us well as we enter into the latter half
of the fiscal year.
As
GenAI becomes pivotal in customer interactions, there is a noticeable trend of
modernization efforts focusing on transforming the data estate. Our robust Data
practice, combined with our innovative LTIMindtree AI platform, establishes us
as a significant disruptor.
| LTIMindtree : Consolidated Results | | | Quarter ended | Year to Date | Year ended |
|---|
| Particulars | 202409 | 202309 | Var.(%) | 202409 | 202309 | Var.(%) | 202403 | 202303 | Var.(%) |
|---|
| Net Sales (including other operating income) | 9,432.90 | 8,905.40 | 5.92 | 18,575.50 | 17,607.50 | 5.50 | 35,517.00 | 33,183.00 | 7.03 | | OPM (%) | 18.01 | 18.32 | -30 bps | 17.79 | 18.55 | -76 bps | 17.98 | 18.41 | -42 bps | | OP | 1,699.30 | 1,631.30 | 4.17 | 3,305.40 | 3,266.80 | 1.18 | 6,387.40 | 6,107.70 | 4.58 | | Other Inc. | 298.90 | 143.20 | 108.73 | 526.00 | 274.80 | 91.41 | 701.90 | 556.90 | 26.04 | | PBIDT | 1,998.20 | 1,774.50 | 12.61 | 3,831.40 | 3,541.60 | 8.18 | 7,089.30 | 6,664.60 | 6.37 | | Interest | 70.30 | 47.00 | 49.57 | 142.70 | 93.00 | 53.44 | 221.70 | 150.40 | 47.41 | | PBDT | 1,927.90 | 1,727.50 | 11.60 | 3,688.70 | 3,448.60 | 6.96 | 6,867.60 | 6,514.20 | 5.43 | | Depreciation | 241.1 | 208.2 | 15.80 | 476.3 | 392.9 | 21.23 | 818.9 | 722.7 | 13.31 | | PBT | 1,686.80 | 1,519.30 | 11.02 | 3212.4 | 3055.7 | 5.13 | 6048.7 | 5791.5 | 4.44 | | Share of Profit/(Loss) from Associates | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | PBT before EO | 1686.8 | 1519.3 | 11.02 | 3212.4 | 3055.7 | 5.13 | 6048.7 | 5791.5 | 4.44 | | EO Income | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | PBT after EO | 1686.8 | 1519.3 | 11.02 | 3212.4 | 3055.7 | 5.13 | 6048.7 | 5791.5 | 4.44 | | Taxation | 435.2 | 357 | 21.90 | 825.7 | 741.1 | 11.42 | 1464.1 | 1381.2 | 6.00 | | PAT | 1251.6 | 1162.3 | 7.68 | 2386.7 | 2314.6 | 3.12 | 4584.6 | 4410.3 | 3.95 | | Minority Interest (MI) | 0.6 | 0.5 | 20.00 | 1.9 | 1.3 | 46.15 | 2.5 | 2 | 25.00 | | Net profit | 1251 | 1161.8 | 7.68 | 2384.8 | 2313.3 | 3.09 | 4582.1 | 4408.3 | 3.94 | | P/(L) from discontinued operations net of tax | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | Net profit after discontinued operations | 1251 | 1161.8 | 7.68 | 2384.8 | 2313.3 | 3.09 | 4582.1 | 4408.3 | 3.94 | | EPS (Rs)* | 42.24 | 39.23 | 7.68 | 80.52 | 78.10 | 3.09 | 154.70 | 148.84 | 3.94 | | | * EPS is on current equity of Rs 29.62 crore, Face value of Rs 1, Excluding extraordinary items. | | # EPS is not annualised | | bps : Basis points | | EO : Extraordinary items | | Figures in Rs crore | | Source: Capitaline Corporate Database |
|
| LTIMindtree : Consolidated Segment Results | td>-| | Quarter ended | Year to Date | Year ended |
|---|
| % of (Total) | 202409 | 202309 | Var.(%) | % of (Total) | 202409 | 202309 | Var.(%) | % of (Total) | 202403 | 202303 | Var.(%) |
|---|
| Sales | | Banking Financial Services | 35.59 | 3,357.30 | 3,251.70 | 3.25 | 35.41 | 6,576.80 | 6,512.10 | 0.99 | 36.15 | 12,840.60 | 12,249.40 | 4.83 | | Manufacturing | 18.11 | 1,708.30 | 1,594.80 | 7.12 | 18.29 | 3,397.20 | 3,100.50 | 9.57 | 18.55 | 6,587.50 | 5,611.00 | 17.40 | | Energy & Utilities | 0.00 | 0.00 | 0.00 | - | | High Tech Media & Entertainment | 25.40 | 2,395.50 | 2,114.30 | 13.30 | 25.50 | 4,736.50 | 4,175.40 | 13.44 | 23.65 | 8,398.70 | 8,066.10 | 4.12 | | CPG Retail Pharma | 14.52 | 1,370.00 | 1,366.90 | 0.23 | 14.53 | 2,698.10 | 2,685.00 | 0.49 | 15.08 | 5,356.00 | 5,112.30 | 4.77 | | Health & Public Services | 6.38 | 601.80 | 577.70 | 4.17 | 6.28 | 1,166.90 | 1,134.50 | 2.86 | 6.57 | 2,334.20 | 2,144.20 | 8.86 | | Total Reported Sales | 100.00 | 9,432.90 | 8,905.40 | 5.92 | 100.00 | 18,575.50 | 17,607.50 | 5.50 | 100.00 | 35,517.00 | 33,183.00 | 7.03 | | Less: Inter segment revenues | | 0.00 | 0.00 | - | | 0.00 | 0.00 | | 0.00 | 0.00 | - | | Net Sales | 100.00 | 9,432.90 | 8,905.40 | 5.92 | 100.00 | 18,575.50 | 17,607.50 | 5.50 | 100.00 | 35,517.00 | 33,183.00 | 7.03 | | PBIT | | Banking Financial Services | 32.38 | 550.30 | 559.20 | -1.59 | 32.03 | 1,058.80 | 1,127.90 | -6.13 | 33.85 | 2,162.10 | 2,175.40 | -0.61 | | Manufacturing | 15.05 | 255.70 | 243.10 | 5.18 | 15.73 | 520.00 | 508.60 | 2.24 | 15.90 | 1,015.40 | 890.20 | 14.06 | | Energy & Utilities | 0.00 | 0.00 | 0.00 | - | | High Tech Media & Entertainment | 31.04 | 527.50 | 503.10 | 4.85 | 31.17 | 1,030.30 | 983.90 | 4.72 | 29.28 | 1,870.30 | 1,722.80 | 8.56 | | CPG Retail Pharma | 15.19 | 258.10 | 267.40 | -3.48 | 14.92 | 493.10 | 514.70 | -4.20 | 15.70 | 1,003.10 | 1,003.50 | -0.04 | | Health & Public Services | 6.34 | 107.70 | 58.50 | 84.10 | 6.15 | 203.20 | 131.70 | 54.29 | 5.27 | 336.50 | 315.80 | 6.55 | | Total PBIT | 100.00 | 1,699.30 | 1,631.30 | 4.17 | 100.00 | 3,305.40 | 3,266.80 | 1.18 | 100.00 | 6,387.40 | 6,107.70 | 4.58 | | Less : Interest | | 70.30 | 47.00 | 49.57 | | 142.70 | 93.00 | 53.44 | | 221.70 | 150.40 | 47.41 | | Add: Other un-allcoable | | 57.80 | -65.00 | LP | | 49.70 | -118.10 | LP | | -117.00 | -165.80 | 29.43 | | PBIT Margin(%) | | Banking Financial Services | | 16.39 | 17.20 | -80.60 | | 16.10 | 17.32 | -122.11 | | 16.84 | 17.76 | -92.12 | | Manufacturing | | 14.97 | 15.24 | -27.52 | | 15.31 | 16.40 | -109.71 | | 15.41 | 15.87 | -45.12 | | Energy & Utilities | | 0.00 | 0.00 | 0.00 | | High Tech Media & Entertainment | | 22.02 | 23.80 | -177.47 | | 21.75 | 23.56 | -181.19 | | 22.27 | 21.36 | 91.04 | | CPG Retail Pharma | | 18.84 | 19.56 | -72.31 | | 18.28 | 19.17 | -89.36 | | 18.73 | 19.63 | -90.06 | | Health & Public Services | | 17.90 | 10.13 | 776.99 | | 17.41 | 11.61 | 580.50 | | 14.42 | 14.73 | -31.20 | | PBT | 100.00 | 1,686.80 | 1,519.30 | 11.02 | 100.00 | 3,212.40 | 3,055.70 | 5.13 | 100.00 | 6,048.70 | 5,791.50 | 4.44 |
|
|